What is the P/E ratio of Zandu Realty . - (Amalgamated)?

The latest standalone P/E ratio of Zandu Realty . - (Amalgamated) as of 01-Jan-1970 is 24.21.

What is the P/B ratio of Zandu Realty . - (Amalgamated)?

The latest standalone P/B ratio of Zandu Realty . - (Amalgamated) as of 01-Jan-1970 is 0.82.

Zandu Realty Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

Name: Zandu Realty . - (Amalgamated)
Brand: Zandu Realty . - (Amalgamated)

BSE: 506720 | NSE: ZANDUREALT | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Zandu Realty-(Amalga

Based on:

Data

M-Cap below 100cr DeciZen not available

Zandu Realty Ltd. - (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

24.21

Market Cap:

152.9 Cr.

52-wk low:

1,850

52-wk high:

1,950.9

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Zandu Realty Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Zandu Realty-(Amalga:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
ROCE % ⓘ	33.7%	42.4%	5.6%	3.3%	-138%	2.9%	54.2%	52%	5.7%	4.2%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	136	87.3	0	0	70	0	29	86.9	8.7	5.1	0
Sales YoY Gr.	-	-35.9%	-100%	NA	NA	-100%	NA	199.3%	-90%	-40.8%	-
Adj EPS ⓘ	196.4	171	16.4	11.3	-871.6	16.7	476.6	797.1	87.4	64.2	78.3
YoY Gr.	-	-12.9%	-90.4%	-30.6%	-7785.6%	NA	2750.4%	67.2%	-89%	-26.5%	-
BVPS (₹) ⓘ	962.9	285.4	302.6	314	887	903.7	1,380.3	2,177.3	2,264.8	2,329	2,303.5
Adj Net Profit ⓘ	15.8	13.8	1.3	0.9	-70.3	1.4	38.4	64.3	7.1	5.2	6
Cash Flow from Ops. ⓘ	22.8	13.5	0	-1.4	72.2	-5	65.6	7	-3	6	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	5	0	1.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-30.5%	-40.7%	-43.9%	-40.8%
Adj EPS ⓘ	-11.7%	NA	-48.7%	-26.5%
BVPSⓘ	10.3%	21.3%	19.1%	2.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	TTM
Return on Equity % ⓘ	21.7	27.4	5.6	0.6	-29.9	0.7	18.6	31.4	3.6	2.6	3.4
Op. Profit Mgn % ⓘ	17.1	20.8	0	0	-102.1	0	77.3	-3.5	-39.2	-72.6	-1607.6
Net Profit Mgn % ⓘ	11.6	15.8	0	0	-100.4	0	132.3	74	81.3	101	6312.6
Debt to Equity ⓘ	0	0	0	0	0	0	0	0.2	0	0.1	-
Working Cap Days ⓘ	86	73	0	0	1,255	0	1,574	492	3,182	2,998	9,338
Cash Conv. Cycle ⓘ	9	4	0	0	941	0	1,369	281	892	969	8,685

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Zandu Realty Ltd. - (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	78.3	156.6
TTM Sales (₹ Cr.)	0.1	104
BVPS (₹.) ⓘ	2,303.5	285.4
Reserves (₹ Cr.) ⓘ	178	15
P/BV ⓘ	0.82	6.64
PE ⓘ	24.21	12.10

From the Market
52 Week Low / High (₹)	1850.00 / 1950.90
All Time Low / High (₹)	650.00 / 24643.20
Market Cap (₹ Cr.)	153
Equity (₹ Cr.)	8.1
Face Value (₹)	100
Industry PE ⓘ	43

Management X-Ray of Zandu Realty-(Amalga:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Zandu Realty-(Amalga

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Zandu Realty-(Amalga

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Sales	136.24	87.29	0	0	70	0	29.04	86.91	8.67	5.13
Operating Expenses ⓘ	113.09	70.33	0.84	0.64	141.43	3.57	6.59	89.93	12.07	8.85
Manufacturing Costs	26.45	17.30	0.14	0.08	0.01	0.02	0.19	0.14	0.04	0.04
Material Costs	37.20	21.20	0	0	139.41	2.56	4.78	82.56	7.55	4.23
Employee Cost	13.65	8.56	0	0	0	0	0	0.05	0.30	0.31
Other Costs ⓘ	35.77	23.27	0.71	0.55	2.02	0.99	1.62	7.18	4.17	4.28
Operating Profit ⓘ	23.15	16.96	-0.84	-0.64	-71.43	-3.57	22.45	-3.02	-3.40	-3.72
Operating Profit Margin (%)	17.0%	19.4%	-	-	-102.0%	-	77.3%	-3.5%	-39.2%	-72.6%
Other Income ⓘ	4.17	5.84	2.16	1.45	4.61	5.68	27.44	86.76	14.54	11.68
Interest ⓘ	0.40	0.24	0	0	0	0	0.34	2.16	2.32	1.42
Depreciation ⓘ	2.62	1.45	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	24.31	21.11	1.32	0.81	-66.82	2.12	49.55	81.58	8.82	6.54
Tax ⓘ	7.90	5.86	-0.07	-0.10	3.46	0.77	11.12	17.30	1.77	1.36
Profit After Tax	16.41	15.25	1.39	0.91	-70.28	1.35	38.43	64.27	7.05	5.18
PAT Margin (%)	12.0%	17.5%	-	-	-100.0%	-	132.3%	74.0%	81.3%	101.0%
Adjusted EPS (₹)	203.5	189.2	17.3	11.3	-871.0	16.7	476.6	797.1	87.4	64.2
Dividend Payout Ratio (%)	37%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Equity and Liabilities
Shareholders Fund	77.65	23.01	24.40	270.30	200.01	201.36	213.05	196.75	196.43	197.49
Share Capital ⓘ	8.06	8.06	8.06	8.06	8.06	8.06	8.06	8.06	8.06	8.06
Reserves ⓘ	69.58	14.95	16.34	262.23	191.95	193.30	204.99	188.69	188.37	189.42
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0.16	0	0	0	0	0	0	35	0	11.40
Long Term Debt	0.16	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	35	0	11.40
Trade Payables	11.28	0.01	0.64	0.03	0	0	0	0	0	0
Others Liabilities ⓘ	16.12	1.05	17.09	9.80	3.74	0.71	56.03	0.59	1.02	0.44
Total Liabilities ⓘ	105.20	24.07	42.13	280.13	203.76	202.07	269.09	232.34	197.46	209.33
Fixed Assets
Gross Block	68.72	0.26	6.26	0	0	0	0	0	0	0
Accumulated Depreciation	50.72	0.24	0.24	0	0	0	0	0	0	0
Net Fixed Assetsⓘ	18	0.02	6.02	0	0	0	0	0	0	0
CWIP ⓘ	26.19	0	0	0	0	0	0	0	0	0
Investmentsⓘ	12.03	22.49	1.46	0.01	0.01	91.51	125.21	135.21	140.09	182.37
Inventories	16.05	0	0	251	111.59	109.03	104.25	21.69	14.14	9.92
Trade Receivables	3.36	0	0	0	0	0	4.57	3.36	3.15	0
Cash Equivalents	12.54	0.65	1.10	2.01	0.67	0.56	3.44	3.36	0.04	0.06
Others Assetsⓘ	17.03	0.92	33.56	27.11	91.48	0.97	31.62	68.73	40.04	16.98
Total Assets ⓘ	105.20	24.07	42.13	280.13	203.76	202.07	269.09	232.34	197.46	209.33

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Cash Flow From Operating Activity ⓘ	22.83	13.52	0.04	-1.36	72.22	-5.01	65.62	7.01	-3.02	5.95
PBT ⓘ	24.31	21.11	1.32	0.81	-66.82	2.12	49.55	81.58	8.82	6.54
Adjustment ⓘ	-0.58	3.08	-1.87	-1.45	-4.56	-5.36	-26.53	-84.88	-12.50	-9.92
Changes in Working Capital ⓘ	6.74	-2.77	0.63	-1.67	144.6	2.35	43.54	39.53	2.43	10.69
Tax Paid ⓘ	-7.65	-7.90	-0.04	0.95	-1	-4.11	-0.94	-29.22	-1.77	-1.36
Cash Flow From Investing Activity ⓘ	-16.76	-17.54	0.29	2.28	-73.56	4.89	-62.72	-39.98	36.60	-15.98
Capex	-10.03	-8.33	-6	0	0	0	0	0	0	0
Net Investments	-4.92	-8.45	21.14	1.45	0	-91.50	-33.70	-10	-4.88	-42.28
Others ⓘ	-1.80	-0.76	-14.85	0.83	-73.56	96.39	-29.02	-29.98	41.48	26.30
Cash Flow From Financing Activityⓘ	-5.94	-2.29	0.12	0	0	0	-0.01	32.88	-36.90	10.06
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	-0.01	-2.12	-1.90	-1.34
Dividend Paid ⓘ	-5	-1.93	0.12	0	0	0	0	0	0	0
Others ⓘ	-0.94	-0.36	0	0	0	0	0	35	-35	11.40
Net Cash Flow ⓘ	0.13	-6.32	0.45	0.92	-1.34	-0.12	2.89	-0.09	-3.32	0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17
Ratios
ROE (%)	22.46	30.31	5.87	3.68	-145.14	1.87	41.73	44.81	3.94	2.8
ROCE (%)	33.74	42.35	5.56	3.27	-138	2.93	54.18	52.03	5.67	4.17
Asset Turnover Ratio	1.57	1.45	0	0	0.29	0	0.12	0.35	0.04	0.03
PAT to CFO Conversion(x)	1.39	0.89	0.03	-1.49	N/A	-3.71	1.71	0.11	-0.43	1.15
Working Capital Days
Receivable Days	8	0	0	0	0	0	57	17	137	0
Inventory Days	41	0	0	0	945	0	1,340	264	755	856
Payable Days	109	97	0	0	0	0	0	0	0	0

Zandu Realty Ltd. - (Amalgamated) Stock News

Zandu Realty Ltd. - (Amalgamated) FAQs

What is the share price of Zandu Realty-(Amalga?

Company share prices are keep on changing according to the market conditions. The closing price of Zandu Realty-(Amalga on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Zandu Realty-(Amalga?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Zandu Realty-(Amalga stood at ₹152.9.

What is the P/E ratio of Zandu Realty-(Amalga?

The latest P/E ratio of Zandu Realty-(Amalga as of 01-Jan-1970 05:30 is 24.21.

What is the P/B ratio of Zandu Realty-(Amalga?

The latest P/B ratio of Zandu Realty-(Amalga as of 01-Jan-1970 05:30 is 0.82.

What is the 52-week high and low of Zandu Realty-(Amalga?

The 52-week high of Zandu Realty-(Amalga is ₹1,950.9 and the 52-week low is ₹1,850.

What is the TTM revenue of Zandu Realty-(Amalga?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zandu Realty-(Amalga is ₹0.10 ( Cr.) .

About Zandu Realty Ltd. - (Amalgamated)

Zandu Pharmaceutical works name was changed to Zandu Realty from March 10, 2010. At present, the company is a multi-product entity, comprising a group of companies. Zandu projects a sale of nearly Rs. 2,000/- Million by 2000 A.D.

It was listed in 1919; is engaged in offering ayurvedic healthcare medicines.

Zandu manufactures a wide range of ayurvedic medicine specialised in area of rheumatology, gynaecology and CNS (Central nervous system).

Using 200 medicinal plants and their extracts it manufactures 300 healthcare products. The company markets its products under the brand name Zandu.

The company exports herbal health care products to U.S.A, Europe and Asian countries.

The chemical division is located at Ankleshwar that manufactures bulk drugs and intermediates. The cosmetics division manufactures wide range of skin care products such as lotion, soaps, shampoo, creams, etc. It markets the cosmetic products under name Z-naree.

It manufactures products such as zandu balm, brento, kesari-jivan, zandu honey, triphala churna, sudarshan, rhumasyl oil, gulbahar, chandra prabhavati, etc.

ZPWL has formed joint venture with Gujarat Agro Industries Corporation to manufacture glycyrrhiza extract from a vegetable plant-extraction project.

In the year 1989 Leopard Investments Private Limited has become the subsidiary of ZPWL.